Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial 30S small ribosomal subunit A-site, also known as the decoding center, is a critical functional region within the prokaryotic ribosome responsible for the accurate translation of genetic information (NIH, 2024). It primarily consists of the 16S ribosomal RNA (rRNA), specifically helix 44, and associated ribosomal proteins (Nature, 2000). During translation, this site monitors the base-pairing between the mRNA codon and the incoming aminoacyl-tRNA anticodon, ensuring high fidelity through a process called decoding (NIH, 2024). This site is a major target for several classes of clinically important antibiotics, most notably aminoglycosides and tetracyclines (StatPearls, 2023). Aminoglycosides bind to the A-site and induce conformational changes that lead to codon misreading and the production of aberrant, toxic proteins (NIH, 2024). Tetracyclines, on the other hand, physically block the entry of aminoacyl-tRNA into the A-site, thereby halting protein synthesis (NIH, 2024). Because of its essential role in bacterial viability, the 30S A-site is a cornerstone for treating a wide range of infections, including sepsis and tuberculosis (StatPearls, 2023). However, its structural similarity to human mitochondrial ribosomes can lead to off-target toxicities such as ototoxicity and nephrotoxicity (NIH, 2024). Resistance mechanisms, such as rRNA methylation or enzymatic modification of drugs, pose significant challenges to therapies targeting this site (Nature, 2000).
Drugs targeting the 30S A-site primarily inhibit protein synthesis by either inducing mRNA misreading or physically blocking the binding of aminoacyl-tRNA. Aminoglycosides bind to the 16S rRNA decoding center, causing a conformational change (flipping of A1492 and A1493) that stabilizes near-cognate tRNA binding, leading to the synthesis of mistranslated, toxic proteins. Tetracyclines bind to the A-site and sterically hinder the attachment of aminoacyl-tRNA to the mRNA-ribosome complex, thereby preventing the elongation of the polypeptide chain.
15 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial 30S small ribosomal subunit A-site (30S A-site).